Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.67M Buy
36,924
+14,160
+62% +$1.01M 0.26% 122
2022
Q3
$1.38M Sell
22,764
-1,050
-4% -$67.1K 0.17% 183
2022
Q2
$1.5M Buy
23,814
+3,049
+15% +$202K 0.17% 205
2022
Q1
$1.46M Buy
20,765
+3,863
+23% +$261K 0.15% 247
2021
Q4
$1.06M Sell
16,902
-207
-1% -$13K 0.1% 344
2021
Q3
$1.06M Buy
17,109
+7,844
+85% +$472K 0.1% 320
2021
Q2
$554K Sell
9,265
-504
-5% -$31.9K 0.05% 444
2021
Q1
$593K Sell
9,769
-75
-0.8% -$4.14K 0.06% 419
2020
Q4
$462K Sell
9,844
-1,460
-13% -$63.3K 0.05% 463
2020
Q3
$420K Buy
11,304
+400
+4% +$15.2K 0.05% 449
2020
Q2
$398K Sell
10,904
-5,735
-34% -$200K 0.05% 448
2020
Q1
$1.9M Sell
16,639
-2,210
-12% -$98K 0.26% 90
2019
Q4
$961K Sell
18,849
-1,065
-5% -$51.4K 0.1% 334
2019
Q3
$939K Sell
19,914
-5,090
-20% -$243K 0.1% 329
2019
Q2
$1.24M Buy
25,004
+2,100
+9% +$98.7K 0.13% 263
2019
Q1
$975K Buy
22,904
+12,805
+127% +$566K 0.09% 329
2018
Q4
$415K Buy
+10,099
New +$433K 0.06% 403

Other funds holding MET

Seeyond's MET Position: Q4 2022 in Review

Seeyond increased its MetLife (MET) stake by 62% in Q4 2022, buying an estimated $1.01M and bringing the position to 36,924 shares worth $2.67M. The position accounts for 0.26% of the portfolio, ranked #122.

Seeyond first reported a position in MET in Q4 2018 and has held it in 17 quarters since. 1,314 funds tracked by Wall St. Rank hold MET as of Q4 2022.

  • Seeyond held 36,924 shares of MetLife worth $2.67M as of Q4 2022.
  • Seeyond bought 14,160 MetLife shares in Q4 2022, an estimated $1.01M.
  • MetLife made up 0.26% of Seeyond's portfolio in Q4 2022, its #122 holding.
  • Seeyond first reported a position in MetLife in Q4 2018 and has held it in 17 quarters since.
  • 1,314 funds tracked by Wall St. Rank held MetLife as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.